Suppr超能文献

种族或族裔与产超广谱β-内酰胺酶的相关性:一项病例对照研究。

Association of Race or Ethnicity With Extended-Spectrum Beta-Lactamase Production in : A Case Control Study.

作者信息

Hemenway Alice N, Biagi Mark, Murrey Timothy F, Sun Jiehuan, Osei-Badu Erica, Salazar-McKinney Adriana, Sanabria Ricardo, Al Zoubi Moamen

机构信息

Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy- Rockford Health Sciences Campus, Rockford, Illinois, USA.

Department of Pharmacy, OSF Saint Anthony Medical Center, Rockford, Illinois, USA.

出版信息

Open Forum Infect Dis. 2024 Oct 10;11(10):ofae516. doi: 10.1093/ofid/ofae516. eCollection 2024 Oct.

Abstract

BACKGROUND

There are limited and conflicting data regarding the impact of race or ethnicity on the rate of gram-negative antimicrobial resistance. This study was performed to determine whether there is a difference in extended-spectrum beta-lactamase (ESBL) infection or colonization in minoritized patients when compared to White patients from a diverse US Midwestern city.

METHODS

A case control study was performed, with controls with non-ESBL matched 1:1 to patients with ESBL-producing based on age, sex, and ZIP code. A variety of other evidence-based factors for ESBL Enterobacterales infection and colonization were collected via chart review. Multivariate conditional logistic regression assessed the odds of minoritized patients as compared to White patients, while controlling for other common risk factors for ESBL Enterobacterales.

RESULTS

A total of 364 matched pairs were included in the analysis. Females were the majority of the sample (91%), with median age of 65 years. The majority of the sample identified as White (73%), followed by Hispanic (14%) and Black (10%). Urine cultures made up the majority of the cultures in the sample (97%), and this was similar between ESBL and non-ESBL groups. While controlling for these risk factors for ESBL , minoritized patients had a statistically significant greater odds of ESBL-producing (odds ratio, 2.53; 95% confidence interval, 1.68-3.82).

CONCLUSIONS

In our sample, which is demographically similar to the United States, minoritized patients had higher odds of ESBL-producing . Further research on the drivers for this disparity is needed.

摘要

背景

关于种族或族裔对革兰氏阴性菌抗菌药物耐药率的影响,现有数据有限且相互矛盾。本研究旨在确定与来自美国中西部一个多元化城市的白人患者相比,少数族裔患者在产超广谱β-内酰胺酶(ESBL)感染或定植方面是否存在差异。

方法

进行了一项病例对照研究,根据年龄、性别和邮政编码,将非ESBL感染的对照与产ESBL的患者按1:1进行匹配。通过病历审查收集了多种其他基于证据的ESBL肠杆菌科感染和定植相关因素。多变量条件逻辑回归评估了少数族裔患者与白人患者相比的比值比,同时控制ESBL肠杆菌科的其他常见风险因素。

结果

分析共纳入364对匹配病例。样本中女性占多数(91%),中位年龄为65岁。样本中大多数人自认为是白人(73%),其次是西班牙裔(14%)和黑人(10%)。尿液培养占样本中培养物的大多数(97%),ESBL组和非ESBL组情况相似。在控制这些ESBL风险因素的情况下,少数族裔患者产ESBL的比值比在统计学上显著更高(比值比为2.53;95%置信区间为1.68 - 3.82)。

结论

在我们这个人口统计学特征与美国相似的样本中,少数族裔患者产ESBL的几率更高。需要对这种差异的驱动因素进行进一步研究。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验